"use strict";(self.webpackChunkdocs=self.webpackChunkdocs||[]).push([[123],{3959:(e,n,t)=>{t.r(n),t.d(n,{assets:()=>c,contentTitle:()=>r,default:()=>h,frontMatter:()=>i,metadata:()=>o,toc:()=>l});var s=t(4848),a=t(8453);const i={output:"docusaurus-md",sidebar_position:4,description:"An example from Belman et al. (2020) showing a complex model with age-dependent relative risks."},r="4) Breast cancer and BRCA1 {#breast-cancer-and-brca1}",o={id:"examples/example4",title:"4) Breast cancer and BRCA1",description:"An example from Belman et al. (2020) showing a complex model with age-dependent relative risks.",source:"@site/docs/examples/example4.md",sourceDirName:"examples",slug:"/examples/example4",permalink:"/shinyseg/examples/example4",draft:!1,unlisted:!1,tags:[],version:"current",sidebarPosition:4,frontMatter:{output:"docusaurus-md",sidebar_position:4,description:"An example from Belman et al. (2020) showing a complex model with age-dependent relative risks."},sidebar:"tutorialSidebar",previous:{title:"3) Two phenotypes",permalink:"/shinyseg/examples/example3"}},c={},l=[{value:"Pedigree table",id:"pedigree-table",level:2},{value:"Penetrance",id:"penetrance",level:2},{value:"FLB",id:"flb",level:2}];function d(e){const n={a:"a",code:"code",em:"em",h1:"h1",h2:"h2",li:"li",p:"p",pre:"pre",strong:"strong",ul:"ul",...(0,a.R)(),...e.components};return(0,s.jsxs)(s.Fragment,{children:[(0,s.jsx)(n.h1,{id:"breast-cancer-and-brca1",children:"4) Breast cancer and BRCA1"}),"\n",(0,s.jsxs)(n.p,{children:["This example is directly taken from ",(0,s.jsx)(n.a,{href:"https://doi.org/10.1038/s41436-020-0920-4",children:"Belman et\nal.\xa0(2020)"}),". It puts to the\ntest shinyseg\u2019s more advanced capabilities by requiring a penetrance\nmodel with age-dependent relative risks and the explicit declaration of\nunobserved phenotypes."]}),"\n",(0,s.jsx)(n.h2,{id:"pedigree-table",children:"Pedigree table"}),"\n",(0,s.jsx)(n.p,{children:"The data corresponding to the case is shown below:"}),"\n",(0,s.jsx)(n.pre,{children:(0,s.jsx)(n.code,{className:"language-text",children:" ped id fid mid sex phenotype carrier proband age\n   1  1   0   0   1    nonaff       .       .  80\n   1  2   0   0   2      BrCa       .       .  65\n   1  3   1   2   2      BrCa     het       .  81\n   1  4   1   2   1    nonaff       .       .  41\n   1  5   0   0   2         .       .       .  89\n   1  6   0   0   1    nonaff       .       .  80\n   1  7   1   2   2    nonaff     het       .  75\n   1  8   1   2   2    nonaff     neg       .  60\n   1  9   4   5   2      BrCa     het       .  41\n   1 10   4   5   2      BrCa     het       .  50\n   1 11   4   5   2    nonaff     het       .  52\n   1 12   6   7   2      BrCa     het       1  49\n   1 13   6   7   1    nonaff     het       .  36\n   1 14   6   7   2      BrCa     het       .  48\n"})}),"\n",(0,s.jsx)("img",{src:t(5832).A,style:{maxHeight:"350px"}}),"\n",(0,s.jsxs)(n.p,{children:["Notice that, together with breast cancer (",(0,s.jsx)(n.code,{children:"BrCa"}),"), the legend includes\novarian (",(0,s.jsx)(n.code,{children:"OvCa"}),") and pancreatic cancer (",(0,s.jsx)(n.code,{children:"PanCa"}),"), even though these are\nnot present in any of the members of the pedigree. This is because they\nare still relevant for computing the penetrances and must be included in\nthe analysis. The next section explains how to do so."]}),"\n",(0,s.jsx)(n.h2,{id:"penetrance",children:"Penetrance"}),"\n",(0,s.jsxs)(n.p,{children:["This analysis employs the default ",(0,s.jsx)(n.code,{children:"Relative risk"})," mode and autosomal\ndominant (",(0,s.jsx)(n.code,{children:"AD"}),") inheritance. When uploading the previous data to the\napp, the relative risk table will only allow parameter setting for\nbreast cancer, as it\u2019s the sole observed phenotype. It will also consist\nof a single row applying to both sexes."]}),"\n",(0,s.jsx)("img",{src:t(7797).A,style:{maxHeight:"400px"}}),"\n",(0,s.jsxs)(n.p,{children:["However, in this case involving breast cancer and BRCA1, it is important\nto incorporate other cancer types to accurately calculate the\npenetrance. This can be achieved by entering their names into the\n",(0,s.jsx)(n.strong,{children:"Extra phenotypes"})," input, located at the bottom of the ",(0,s.jsx)(n.em,{children:"Penetrance"}),"\npanel. Moreover, we need to declare sex-specific penetrances. This can\nbe easily done by clicking on the cells of the sex column and changing\n",(0,s.jsx)(n.code,{children:"both"})," to any of the sexes. With that done, the table will appear as\nfollows:"]}),"\n",(0,s.jsx)("img",{src:t(4535).A,style:{maxHeight:"600px"}}),"\n",(0,s.jsxs)(n.p,{children:["We are now ready to start filling in the table, using the same sources\nas in ",(0,s.jsx)(n.a,{href:"https://doi.org/10.1038/s41436-020-0920-4",children:"Belman et al.\xa0(2020)"}),":"]}),"\n",(0,s.jsxs)(n.ul,{children:["\n",(0,s.jsxs)(n.li,{children:["\n",(0,s.jsxs)(n.p,{children:["For the baseline parameters (",(0,s.jsx)(n.code,{children:"neg risk"}),", ",(0,s.jsx)(n.code,{children:"neg mean"}),", ",(0,s.jsx)(n.code,{children:"neg SD"}),"), we\nemployed the UK 2008-2012 estimates from ",(0,s.jsx)(n.a,{href:"https://ci5.iarc.fr",children:"Cancer Incidence in Five\nContinents (CI5)"}),". The optimal parameters for\neach cancer type were identified by using shinyseg\u2019s\n",(0,s.jsx)(n.a,{href:"../how-to/penetrance#optimal-parameters",children:(0,s.jsx)(n.strong,{children:"Assistant"})}),"."]}),"\n"]}),"\n",(0,s.jsxs)(n.li,{children:["\n",(0,s.jsxs)(n.p,{children:["The ",(0,s.jsx)(n.code,{children:"hazard ratios(s)"})," were adapted from ",(0,s.jsx)(n.a,{href:"https://fenglab.chpc.utah.edu/cool2/manual.html",children:"COOL\u2019s\nwebsite"}),". We\nspecified the hazard ratios at ages approximately 1, 20, 40, 60, 80,\nand 100, which are then interpolated/smoothed by the app as shown\nbelow."]}),"\n"]}),"\n"]}),"\n",(0,s.jsx)("img",{src:t(4920).A,style:{maxHeight:"600px"}}),"\n",(0,s.jsx)(n.h2,{id:"flb",children:"FLB"}),"\n",(0,s.jsxs)(n.p,{children:["Finally, we can ",(0,s.jsx)(n.strong,{children:"Calculate"})," the Bayes factor, which in this case\npoints to ",(0,s.jsx)(n.em,{children:"inconclusive"})," evidence for pathogenicity. While this\nconclusion aligns with that of ",(0,s.jsx)(n.a,{href:"https://doi.org/10.1038/s41436-020-0920-4",children:"Belman et\nal.\xa0(2020)"}),", we note a slight\nquantitative deviation (",(0,s.jsx)(n.code,{children:"5.7"})," vs.\xa0",(0,s.jsx)(n.code,{children:"3.9"}),") which is primarily due to how\nshinyseg utilizes model-based estimates instead of the raw data."]}),"\n",(0,s.jsx)("img",{src:t(4083).A,style:{maxHeight:"150px"}}),"\n",(0,s.jsx)(n.p,{children:"The payoff of shinyseg\u2019s set up is that sensitivity analyses can now be\neasily performed by altering a reasonable number of parameters."})]})}function h(e={}){const{wrapper:n}={...(0,a.R)(),...e.components};return n?(0,s.jsx)(n,{...e,children:(0,s.jsx)(d,{...e})}):d(e)}},4083:(e,n,t)=>{t.d(n,{A:()=>s});const s=t.p+"assets/images/ex4-flb-864b241d42e875f590e979a2ea7c8203.png"},5832:(e,n,t)=>{t.d(n,{A:()=>s});const s=t.p+"assets/images/ex4-ped-1d4a1562afb9372e0d95c59c3d6d3163.png"},7797:(e,n,t)=>{t.d(n,{A:()=>s});const s=t.p+"assets/images/ex4-rrisk-tab1-36d89df57fe257762e2145cc20cc6bdf.png"},4535:(e,n,t)=>{t.d(n,{A:()=>s});const s=t.p+"assets/images/ex4-rrisk-tab3-9d7f0c96dbc94f282d8079d5d7319307.png"},4920:(e,n,t)=>{t.d(n,{A:()=>s});const s=t.p+"assets/images/ex4-rrisk-tab4-5e0c860e2ccbc3d6580697ecc13c0385.png"},8453:(e,n,t)=>{t.d(n,{R:()=>r,x:()=>o});var s=t(6540);const a={},i=s.createContext(a);function r(e){const n=s.useContext(i);return s.useMemo((function(){return"function"==typeof e?e(n):{...n,...e}}),[n,e])}function o(e){let n;return n=e.disableParentContext?"function"==typeof e.components?e.components(a):e.components||a:r(e.components),s.createElement(i.Provider,{value:n},e.children)}}}]);